Similar articles for PMID: 30676480

Year	Number of Results
1975	1
1997	1
2000	1
2002	1
2003	1
2004	3
2005	5
2006	5
2007	6
2008	5
2009	7
2010	4
2011	9
2012	8
2013	6
2014	6
2015	13
2016	13
2017	6
2018	6
2019	9
2020	5
2021	3
2022	5
2023	4
2024	0

1

Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients.

Okin PM, Kjeldsen SE, Devereux RB. Okin PM, et al. J Hypertens. 2019 Mar;37(3):629-635. doi: 10.1097/HJH.0000000000001915. J Hypertens. 2019. PMID: 30676480

2

Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease.

Dewland TA, Soliman EZ, Davis BR, Magnani JW, Yamal JM, Piller LB, Haywood LJ, Alonso A, Albert CM, Marcus GM; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group. Dewland TA, et al. JAMA Intern Med. 2016 Aug 1;176(8):1085-92. doi: 10.1001/jamainternmed.2016.2502. JAMA Intern Med. 2016. PMID: 27367818 Clinical Trial.

3

Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) study.

Zhang ZM, Rautaharju PM, Soliman EZ, Manson JE, Martin LW, Perez M, Vitolins M, Prineas RJ. Zhang ZM, et al. Circ Heart Fail. 2013 Jul;6(4):655-61. doi: 10.1161/CIRCHEARTFAILURE.113.000217. Epub 2013 May 31. Circ Heart Fail. 2013. PMID: 23729198 Free PMC article.

4

Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.

Kristensen SL, Castagno D, Shen L, Jhund PS, Docherty KF, Rørth R, Abraham WT, Desai AS, Dickstein K, Rouleau JL, Zile MR, Swedberg K, Packer M, Solomon SD, Køber L, McMurray JJV; PARADIGM-HF and ATMOSPHERE Committees and Investigators.. Kristensen SL, et al. Eur J Heart Fail. 2020 Dec;22(12):2370-2379. doi: 10.1002/ejhf.1972. Epub 2020 Sep 14. Eur J Heart Fail. 2020. PMID: 32720404 Free article.

5

Scar burden, not intraventricular conduction delay pattern, is associated with outcomes in ischemic cardiomyopathy patients receiving cardiac resynchronization therapy.

Adelstein EC, Althouse AD, Schwartzman D, Jain SK, Soman P, Saba S. Adelstein EC, et al. Heart Rhythm. 2018 Nov;15(11):1664-1672. doi: 10.1016/j.hrthm.2018.05.027. Epub 2018 May 28. Heart Rhythm. 2018. PMID: 29852239

6

Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry.

Lund LH, Benson L, Ståhlberg M, Braunschweig F, Edner M, Dahlström U, Linde C. Lund LH, et al. Eur J Heart Fail. 2014 Oct;16(10):1073-81. doi: 10.1002/ejhf.162. Epub 2014 Sep 8. Eur J Heart Fail. 2014. PMID: 25201219 Free article.

7

Ventricular conduction defects and the risk of incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study.

Zhang ZM, Rautaharju PM, Prineas RJ, Loehr L, Rosamond W, Soliman EZ. Zhang ZM, et al. J Card Fail. 2015 Apr;21(4):307-12. doi: 10.1016/j.cardfail.2015.01.001. Epub 2015 Jan 9. J Card Fail. 2015. PMID: 25582389 Free PMC article.

8

Bundle branch blocks and the risk of mortality in the Atherosclerosis Risk in Communities study.

Zhang ZM, Rautaharju PM, Prineas RJ, Loehr L, Rosamond W, Soliman EZ. Zhang ZM, et al. J Cardiovasc Med (Hagerstown). 2016 Jun;17(6):411-7. doi: 10.2459/JCM.0000000000000235. J Cardiovasc Med (Hagerstown). 2016. PMID: 25575277

9

Effect of Left Ventricular Conduction Delay on All-Cause and Cardiovascular Mortality (from the PRECISION Trial).

Kiehl EL, Menon V, Mandsager KT, Wolski KE, Wisniewski L, Nissen SE, Lincoff AM, Borer JS, Lüscher TF, Cantillon DJ. Kiehl EL, et al. Am J Cardiol. 2019 Oct 1;124(7):1049-1055. doi: 10.1016/j.amjcard.2019.06.024. Epub 2019 Jul 15. Am J Cardiol. 2019. PMID: 31395295 Clinical Trial.

10

Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).

Aranda JM Jr, Conti JB, Johnson JW, Petersen-Stejskal S, Curtis AB. Aranda JM Jr, et al. Clin Cardiol. 2004 Dec;27(12):678-82. doi: 10.1002/clc.4960271204. Clin Cardiol. 2004. PMID: 15628109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year